E-commerce sucks investment away from med-tech, says Bard
This article was originally published in Clinica
Executive Summary
The chairman and CEO of CR Bard, William Longfield, has attacked those investors who are ignoring the value of successful companies such as Bard and choosing to divert their money into the e-commerce sector of the market. The result is that Bard's share price has been low, despite its sales and profit performance.